Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV01E vs CoronaVac COVID-19 Booster Vaccine
NCT05683561Phase 3Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of SCTV01E in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Sinocelltech Group Limited. Primary endpoint: Cases of the first occurrence of symptomatic COVID-19 of any severity starting 14 days (≥15 days) after the study vaccination. Status: unknown.
02
Drugs
SCTV01E
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05683561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683561.